- You are here: Home
- Applications
- 3D Spheroid & Organoid Culture
- Organ-on-a-Chip Platform for Drug Development
Applications
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Organ-on-a-Chip Platform for Drug Development
Organ-on-a-Chip technology involves the development of microphysiological systems (MPSs) that replicate the essential components of an organ's microenvironment, including living cells, tissue interfaces, biological fluids, and mechanical forces, all integrated onto a chip. These in vitro organoid models can effectively simulate both physiological and pathological activities of human organs, enabling researchers to study various biological behaviors in a controlled and observable way. Additionally, they facilitate predictions of the human body's response to different drug stimuli. The advanced human organoid model, constructed on an organoid chip, accurately reproduces the complex structure and physiological functions of human organs within the laboratory. This innovative technology yields more precise experimental data compared to traditional two-dimensional cell models and animal testing methods.
Organ-on-a-Chip technology offers several advantages, including miniaturization, integration, and low resource consumption. Additionally, it allows researchers to meticulously control various parameters within the system, such as chemical concentration gradients, fluid shear stress, cell patterning, tissue-tissue interfaces, and organ-organ interactions. The goal is to accurately replicate the complex structures, microenvironments, and physiological functions of human organs.
Figure 1. Organ-on-a-Chip technology has been used to model nearly all human organs for purposes such as drug testing, disease modeling, and personalized medicine. [1]
Creative Bioarray focuses on developing specific human disease models and leveraging our organ-on-a-chip platform to identify new therapeutics and clinical biomarkers, promote drug development, and create novel drug delivery systems. Our organ-on-a-chip solutions offer innovative methods for culturing cells and tissues, providing precise and continuous control throughout the entire culturing process. Several chip designs are available for organ-on-a-chip experiments, tailored to the specific organs scientists wish to mimic and the experimental protocols they are using.
Single-organ-on-a-chip
Multi-organ-on-a-chip
Reference
- Deng, Shiwen et al. "Organ-on-a-chip meets artificial intelligence in drug evaluation." Theranostics vol. 13,13 4526-4558. 15 Aug. 2023, doi:10.7150/thno.87266
Explore Other Options
For research use only. Not for any other purpose.